# Protalix BioTherapeutics, Inc.: Form 8-K, filed Aug 7, 2023

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2023-08-07
- Accepted by EDGAR: Aug 7, 2023, 10:59 ET
- Period: 2023-08-07
- Accession: 0001558370-23-013481
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837023013481/plx-20230807x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837023013481/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837023013481/plx-20230807x8k.htm

Filed Aug 7, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-013481. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.